Close

GlaxoSmithKline (GSK) Announces Filing Regulatory Submission with EMA for FF/UMEC/VI as COPD Treatment

December 2, 2016 9:17 AM EST Send to a Friend
GlaxoSmithKline plc (NYSE: GSK) and Innoviva, Inc. (Nasdaq: INVA) announced the filing by GSK of a regulatory submission with the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login